Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of Hematology (ASH) 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback